BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

590 related articles for article (PubMed ID: 36645300)

  • 1. Antiviral Approaches against Influenza Virus.
    Kumari R; Sharma SD; Kumar A; Ende Z; Mishina M; Wang Y; Falls Z; Samudrala R; Pohl J; Knight PR; Sambhara S
    Clin Microbiol Rev; 2023 Mar; 36(1):e0004022. PubMed ID: 36645300
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Antiviral resistance in influenza viruses.
    Márquez Domínguez L; Márquez Matla K; Reyes Leyva J; Vallejo Ruíz V; Santos López G
    Cell Mol Biol (Noisy-le-grand); 2023 Dec; 69(13):16-23. PubMed ID: 38158694
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Drug Repurposing Approaches for the Treatment of Influenza Viral Infection: Reviving Old Drugs to Fight Against a Long-Lived Enemy.
    Pizzorno A; Padey B; Terrier O; Rosa-Calatrava M
    Front Immunol; 2019; 10():531. PubMed ID: 30941148
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Universal influenza virus vaccines and therapeutic antibodies.
    Nachbagauer R; Krammer F
    Clin Microbiol Infect; 2017 Apr; 23(4):222-228. PubMed ID: 28216325
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Antiviral Peptides as Anti-Influenza Agents.
    Agamennone M; Fantacuzzi M; Vivenzio G; Scala MC; Campiglia P; Superti F; Sala M
    Int J Mol Sci; 2022 Sep; 23(19):. PubMed ID: 36232735
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Prophylaxis and treatment of influenza virus infection.
    Kandel R; Hartshorn KL
    BioDrugs; 2001; 15(5):303-23. PubMed ID: 11437694
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Antiviral drugs in influenza: an adjunct to vaccination in some situations.
    Prescrire Int; 2006 Feb; 15(81):21-30. PubMed ID: 16548114
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Antivirals Targeting the Surface Glycoproteins of Influenza Virus: Mechanisms of Action and Resistance.
    Bai Y; Jones JC; Wong SS; Zanin M
    Viruses; 2021 Apr; 13(4):. PubMed ID: 33917376
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Advanced drug delivery systems can assist in managing influenza virus infection: A hypothesis.
    Chan Y; Ng SW; Mehta M; Anand K; Kumar Singh S; Gupta G; Chellappan DK; Dua K
    Med Hypotheses; 2020 Nov; 144():110298. PubMed ID: 33254489
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Novel strategies for prevention and treatment of influenza.
    Kandel R; Hartshorn KL
    Expert Opin Ther Targets; 2005 Feb; 9(1):1-22. PubMed ID: 15757479
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Antiviral drugs for influenza.
    Med Lett Drugs Ther; 2009 Nov; 51(1325):89-92. PubMed ID: 20220738
    [No Abstract]   [Full Text] [Related]  

  • 12. A brief review of influenza virus infection.
    Javanian M; Barary M; Ghebrehewet S; Koppolu V; Vasigala V; Ebrahimpour S
    J Med Virol; 2021 Aug; 93(8):4638-4646. PubMed ID: 33792930
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Disruption of virus-host cell interactions and cell signaling pathways as an anti-viral approach against influenza virus infections.
    Ludwig S
    Biol Chem; 2011 Oct; 392(10):837-47. PubMed ID: 21823902
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Influenza Virus: Small Molecule Therapeutics and Mechanisms of Antiviral Resistance.
    Han J; Perez J; Schafer A; Cheng H; Peet N; Rong L; Manicassamy B
    Curr Med Chem; 2018; 25(38):5115-5127. PubMed ID: 28933281
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Vaccination with Recombinant Parainfluenza Virus 5 Expressing Neuraminidase Protects against Homologous and Heterologous Influenza Virus Challenge.
    Mooney AJ; Gabbard JD; Li Z; Dlugolenski DA; Johnson SK; Tripp RA; He B; Tompkins SM
    J Virol; 2017 Dec; 91(23):. PubMed ID: 28931689
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Anti-Influenza Drug Discovery and Development: Targeting the Virus and Its Host by All Possible Means.
    Terrier O; Slama-Schwok A
    Adv Exp Med Biol; 2021; 1322():195-218. PubMed ID: 34258742
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Broad and Protective Influenza B Virus Neuraminidase Antibodies in Humans after Vaccination and their Clonal Persistence as Plasma Cells.
    Piepenbrink MS; Nogales A; Basu M; Fucile CF; Liesveld JL; Keefer MC; Rosenberg AF; Martinez-Sobrido L; Kobie JJ
    mBio; 2019 Mar; 10(2):. PubMed ID: 30862743
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Promises and challenges of single-domain antibodies to control influenza.
    Matthys A; Saelens X
    Antiviral Res; 2024 Feb; 222():105807. PubMed ID: 38219914
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Antivirals and the control of influenza outbreaks.
    Hota S; McGeer A
    Clin Infect Dis; 2007 Nov; 45(10):1362-8. PubMed ID: 17968836
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Antiviral strategies against influenza virus: towards new therapeutic approaches.
    Loregian A; Mercorelli B; Nannetti G; Compagnin C; Palù G
    Cell Mol Life Sci; 2014 Oct; 71(19):3659-83. PubMed ID: 24699705
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 30.